< Back to previous pageResearcher Gigly Del'HayeResearch Expertise: MetabolomicsChemometricsUPLC-ESI-QToF MSSFC-ESI-QToF MS Keywords:Pharmacy and pharmacologyUsers of research expertise: MetabolomicsChemometricsUPLC-ESI-QToF MSSFC-ESI-QToF MS AffiliationsExperimental in vitro toxicology and dermato-cosmetology (Research group)MemberFrom1 Oct 2022 → TodayVrije Universiteit BrusselFaculty of Medicine and Pharmacy (Faculty)MemberFrom2 Sep 2021 → TodayVrije Universiteit BrusselPharmaceutical and Pharmacological Sciences (Department)MemberFrom1 Oct 2022 → TodayVrije Universiteit BrusselPharmaceutical and Pharmacological Sciences (Department)MemberFrom1 Sep 2021 → 20 Oct 2022Vrije Universiteit BrusselPharmaceutical and Pharmacological Sciences (Department)MemberFrom1 Sep 2021 → 30 Sep 2022Vrije Universiteit BrusselDepartment of Analytical Chemistry, Applied Chemometrics and Molecular Modelling (Research group)MemberFrom19 Sep 2019 → 1 Jan 2023Vrije Universiteit BrusselFaculty of Medicine and Pharmacy (Faculty)MemberFrom19 Sep 2019 → 23 Jun 2021Vrije Universiteit BrusselPublications1 - 1 of 1Development of an adverse outcome pathway network for breast cancer: a comprehensive representation of the pathogenesis, complexity and diversity of the disease(2022)Authors: Gigly Del'Haye, Ine Nulmans, Sandrine Paula Bouteille, Karolien Sermon, Brecht Wellekens, Matthias Rombaut, Tamara Vanhaecke, Yvan Vander Heyden, Joery De KockPages: 2881-2897
